Certara Discovery – Streamline Your Drug Discovery Process

Certara acquired Chemaxon in 2024 to unite best-in-class scientific informatics solutions, enabling chemists to improve the efficiency and quality of drug discovery. This brochure outlines the combined capabilities of D360 and Chemaxon, which offer the industry’s leading core chemistry foundation, compound registration, self-service data access, data analytics leading to SAR, and tracking of scientific hypotheses and designs.